Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: This is a unique opportunity for an experienced Clinical Operations professional with strong expertise in Medical Affairs–owned Externally Sponsored Research (ESR) and a solid understanding of clinical operations, Good Clinical Practice (GCP), and U.S. Food and Drug Administration (FDA) regulatory requirements. Oncology experience is preferred. As the Clinical Operations Manager, Medical Affairs ESR Program, reporting to the Director, Clinical Operations – Medical Affairs, you will be responsible for Clinical Operations oversight of ESR studies following approval, from protocol development through study close-out. This role serves as the primary Clinical Operations owner for ESR execution, ensuring compliant study activation, ongoing oversight, and documentation of sponsor responsibilities in alignment with internal SOPs and regulatory expectations. Specifically, you will be responsible for:
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level